We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.
- Authors
Broos, Nancy; van Puijenbroek, Eugène P; van Grootheest, Kees
- Abstract
In November 2009, all children in the Netherlands from 6 months up to 4 years of age were indicated to receive the Influenza A (H1N1) vaccine. Fever is a common adverse event following immunization in children. Pandemrix®, an inactivated, split-virus influenza A (H1N1) vaccine, was used for this age group. A clinical study mentioned in the Summary of Product Characteristics of Pandemrix® found an increased reactogenicity after the second dose in comparison with the first dose, particularly in the rate of fever. In the Netherlands, this adverse reaction was a point of concern for the parents or caregivers of these children.
- Publication
Drug safety, 2010, Vol 33, Issue 12, p1109
- ISSN
1179-1942
- Publication type
Journal Article
- DOI
10.2165/11539280-000000000-00000